| Reagan-Udall Foundation

Read more about Master Rollover Protocol for Continued Safety Assessment of Study Drug

Read more about CTL019 Out of Specification MAP for ALL or DLBCL Patients

Read more about Expanded Access IND Administration of HBOC-201 in Patients with Severe Acute Anemia

Read more about Individual Patient Compassionate Use of Fedratinib

Read more about Expanded Access of Vigil in Solid Tumors

Read more about Intermediate Expanded Access Protocol CNMAu8.EAP03

Read more about Expanded Access to Ensartinib for Participants With ALK+ NSCLC

Read more about Early Access Program With Arimoclomol in US Patients With NPC

Read more about Expanded Access for ATB200/AT2221 for the Treatment of IOPD

Read more about A Single Patient Compassionate Use of MBM-02 (Tempol) for the Treatment of Prostate Cancer